Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $3.29 and traded as high as $3.78. Evotec shares last traded at $3.78, with a volume of 103,260 shares traded.
Evotec Stock Down 3.4%
The stock has a market capitalization of $1.21 billion, a price-to-earnings ratio of 8.90 and a beta of 0.98. The firm’s fifty day moving average is $3.29 and its 200-day moving average is $3.57. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50.
Evotec Company Profile
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Read More
- Five stocks we like better than Evotec
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Become a 2x better options trader (in 2 days)
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
